Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Rane

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 22, 2004
The impact of CYP2C9 genetics and oral contraceptives on cytochrome P450 2C9 phenotypeMia Sandberg, Inger Johansson, Magnus Christensen, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 22, 2017
Combined effect of telmisartan and fluvastatin on arachidonic acid metabolism in human liver microsomesYuka Kato, Yuji Mukai, Anders Rane, et al.
Basic & Clinical Pharmacology & Toxicology|August 12, 2009
Roles of different CYP enzymes in the formation of specific fluvastatin metabolites by human liver microsomesTakaki Toda, Erik Eliasson, Birgitta Ask, et al.
British Journal of Clinical Pharmacology|June 21, 2005
Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tractMari Thörn, Niklas Finnström, Stefan Lundgren, et al.
Frontiers in Endocrinology|June 28, 2013
Implication of Human UGT2B7, 2B15, and 2B17 in 19-Norandrosterone MetabolismEmmanuel Strahm, Ulf Sjöberg, Mats Garle, et al.
Pharmacogenomics|December 11, 2012
Institutional profile: Karolinska InstitutetErik Eliasson, Sarah C Sim, Anders Rane, et al.
Fundamental & Clinical Pharmacology|July 20, 2007
Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish populationJohanna Hilli, Anders Rane, Stefan Lundgren, et al.
Steroids|August 1, 2009
Non-steroidal anti-inflammatory drugs interact with testosterone glucuronidationTaina Sten, Moshe Finel, Birgitta Ask, et al.
European Journal of Clinical Pharmacology|November 26, 2008
Influence of CYP2C9 genotype on warfarin dose requirements--a systematic review and meta-analysisJonatan D Lindh, Lennart Holm, Marine L Andersson, et al.
British Journal of Clinical Pharmacology|November 26, 2002
The effect of the CYP1A2 *1F mutation on CYP1A2 inducibility in pregnant womenAnna Nordmark, Stefan Lundgren, Birgitta Ask, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 22, 2004
The impact of CYP2C9 genetics and oral contraceptives on cytochrome P450 2C9 phenotypeMia Sandberg, Inger Johansson, Magnus Christensen, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 22, 2017
Combined effect of telmisartan and fluvastatin on arachidonic acid metabolism in human liver microsomesYuka Kato, Yuji Mukai, Anders Rane, et al.
Basic & Clinical Pharmacology & Toxicology|August 12, 2009
Roles of different CYP enzymes in the formation of specific fluvastatin metabolites by human liver microsomesTakaki Toda, Erik Eliasson, Birgitta Ask, et al.
British Journal of Clinical Pharmacology|June 21, 2005
Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tractMari Thörn, Niklas Finnström, Stefan Lundgren, et al.
Frontiers in Endocrinology|June 28, 2013
Implication of Human UGT2B7, 2B15, and 2B17 in 19-Norandrosterone MetabolismEmmanuel Strahm, Ulf Sjöberg, Mats Garle, et al.
Pharmacogenomics|December 11, 2012
Institutional profile: Karolinska InstitutetErik Eliasson, Sarah C Sim, Anders Rane, et al.
Fundamental & Clinical Pharmacology|July 20, 2007
Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish populationJohanna Hilli, Anders Rane, Stefan Lundgren, et al.
Steroids|August 1, 2009
Non-steroidal anti-inflammatory drugs interact with testosterone glucuronidationTaina Sten, Moshe Finel, Birgitta Ask, et al.
European Journal of Clinical Pharmacology|November 26, 2008
Influence of CYP2C9 genotype on warfarin dose requirements--a systematic review and meta-analysisJonatan D Lindh, Lennart Holm, Marine L Andersson, et al.
British Journal of Clinical Pharmacology|November 26, 2002
The effect of the CYP1A2 *1F mutation on CYP1A2 inducibility in pregnant womenAnna Nordmark, Stefan Lundgren, Birgitta Ask, et al.
Pageof 12